Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varied Remimazolam Dosages for Pediatric Endoscopy
NCT07083440Completed
- Sponsor
- Hebei Children's Hospital
- Start
- Jun 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in gastrointestinal disease (3 arms), sponsored by Hebei Children's Hospital. Primary endpoints: Total Propofol Dosage and Incidence of Hypotension. Started Jun 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
gastrointestinal disease
Beyond the preview
Go deeper on NCT07083440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07083440.